‡ In these countries please contact our distributor
Learn more about our participation in GS1 and UDI initiatives
More关于GS1 UDI倡议
Learn more about product patents applicable in the United States only.
dota2雷竞技
We invested $292 million in Research and Development (R&D) in 2019, equivalent to 5.7% of Group revenue.
Moreabout Research and Development
Detailed information on reimbursement guidelines, codes, payment methodologies and a reimbursement calculation tool for our surgical devices and products.
Moreabout US Reimbursement